Update on bacteraemia in oncology and hematology

Area of Science:

• Oncology
• Hematology
• Infectious Diseases
• Microbiology

Background:

• Bacteremia poses a significant risk to patients undergoing cancer treatment.
• Neutropenia in onco-hematologic patients increases susceptibility to infections.
• The emergence of multi-drug resistant organisms presents a growing challenge.

Purpose of the Study:

• To provide an updated literature review on bloodstream infections in onco-hematologic patients.
• To discuss recent advances in the epidemiology and management of these infections.
• To highlight key areas of interest, including risk stratification and antimicrobial resistance.

Main Methods:

• A multidisciplinary group of Spanish physicians reviewed recent relevant literature.
• Selected papers cover basic science, epidemiology, causative microorganisms, and clinical syndromes.
• Focus on studies assessing fever management in neutropenic patients and risk prediction scores.

Main Results:

• Recent literature emphasizes diverse strategies for fever management in neutropenic patients.
• Validation of specific clinical scores aids in risk assessment for bacteremia.
• Early identification of patients susceptible to bacterial infections and multi-drug resistant organisms is crucial.

Conclusions:

• Effective management of bacteremia in onco-hematologic patients requires a multidisciplinary approach.
• Risk stratification tools are essential for timely and appropriate interventions.
• Continuous monitoring and research are needed to combat evolving antimicrobial resistance patterns.